Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)

Hundscheid, T.; Onland, W.; Overmeire, B. van; Dijk, P.; Kaam, A.H.L.C. van; Dijkman, K.P.; ... ; Boode, W.P. de (2018)

Article / Letter to editor

• Prematurity
• Patent ductus arteriosus
• Neonatal intensive care unit
• Ibuprofen
• Expectative management
• Ductal ligation
• Mortality
• Necrotising enterocolitis
• Bronchopulmonary dysplasia
• Cost-effectiveness

• All authors: Hundscheid, T.; Onland, W.; Overmeire, B. van; Dijk, P.; Kaam, A.H.L.C. van; Dijkman, K.P.; Kooi, E.M.W.; Villamor, E.; Kroon, A.A.; Visser, R.; Vijlbrief, D.C.; Tollenaer, S.M. de; Cools, F.; Laere, D. van; Johansson, A.B.; Hocq, C.; Zecic, A.; Adang, E.; Donders, R.; Vries, W. de; Heijst, A.F.J. van; Boode, W.P. de
• Date: 2018-08-04
• Journal: BMC Pediatrics
• Volume: 18
• DOI: doi:10.1186/s12887-018-1215-7